Trial Profile

TreximetTM in the Prevention and Modification of Disease Progression in Migraine

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naproxen sodium/sumatriptan (Primary) ; Naproxen sodium
Indications Migraine
Focus Therapeutic Use

Most Recent Events

30 Jun 2013 Results presented at the 2013 International Headache Congress.
27 Jun 2013 Results presented at the 2013 International Headache Congress .
23 Apr 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com